- Report
- January 2026
- 400 Pages
Global
From €5254EUR$6,119USD£4,350GBP
- Report
- August 2026
- 240 Pages
Global
From €4265EUR$4,799USD£3,654GBP
- Report
- August 2026
- 195 Pages
Global
From €3150EUR$3,545USD£2,700GBP
€3500EUR$3,939USD£3,000GBP
- Report
- August 2026
- 121 Pages
Global
From €5198EUR$5,850USD£4,455GBP
- Report
- January 2026
- 182 Pages
Global
From €3999EUR$4,500USD£3,427GBP
- Report
- April 2026
- 167 Pages
Global
From €4221EUR$4,750USD£3,617GBP
- Report
- February 2026
- 137 Pages
Global
From €2665EUR$2,999USD£2,284GBP
€3554EUR$3,999USD£3,045GBP
- Report
- January 2026
- 146 Pages
Global
From €3510EUR$3,950USD£3,008GBP
- Report
- July 2026
- 218 Pages
Global
From €4265EUR$4,799USD£3,654GBP
- Report
- August 2026
- 193 Pages
Global
From €3150EUR$3,545USD£2,700GBP
€3500EUR$3,939USD£3,000GBP
- Report
- August 2026
- 185 Pages
Global
From €3150EUR$3,545USD£2,700GBP
€3500EUR$3,939USD£3,000GBP
- Report
- January 2026
- 198 Pages
Global
From €3150EUR$3,545USD£2,700GBP
€3500EUR$3,939USD£3,000GBP
- Report
- January 2026
- 180 Pages
Global
From €3150EUR$3,545USD£2,700GBP
€3500EUR$3,939USD£3,000GBP
- Report
- January 2026
- 192 Pages
Global
From €3150EUR$3,545USD£2,700GBP
€3500EUR$3,939USD£3,000GBP
- Report
- August 2026
- 474 Pages
Global
From €5198EUR$5,850USD£4,455GBP
- Report
- August 2026
- 451 Pages
Global
From €5198EUR$5,850USD£4,455GBP
- Report
- August 2026
- 184 Pages
Global
From €5198EUR$5,850USD£4,455GBP
- Report
- August 2026
- 187 Pages
Global
From €3150EUR$3,545USD£2,700GBP
€3500EUR$3,939USD£3,000GBP
- Report
- August 2026
- 183 Pages
Global
From €3150EUR$3,545USD£2,700GBP
€3500EUR$3,939USD£3,000GBP
- Report
- August 2026
- 186 Pages
Global
From €3150EUR$3,545USD£2,700GBP
€3500EUR$3,939USD£3,000GBP

The Anti-Obesity Drugs market is a sector of the pharmaceutical industry that focuses on the development and sale of drugs designed to reduce or prevent obesity. These drugs are typically prescribed to individuals who are overweight or obese and are at risk of developing health complications due to their weight. Commonly prescribed anti-obesity drugs include orlistat, lorcaserin, and phentermine. These drugs work by suppressing appetite, increasing metabolism, or blocking the absorption of fat.
The Anti-Obesity Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include GlaxoSmithKline, Novo Nordisk, Sanofi, Pfizer, and Merck. These companies are constantly developing new drugs and treatments to meet the needs of their customers. Show Less Read more